Ignite Creation Date:
2025-12-24 @ 5:44 PM
Ignite Modification Date:
2025-12-28 @ 5:17 AM
Study NCT ID:
NCT00751868
Status:
COMPLETED
Last Update Posted:
2014-12-17
First Post:
2008-09-11
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
FEC With G-CSF Support Followed by Ixabepilone With G-CSF Support as Neoadjuvant Chemotherapy in BC
Sponsor:
Consorzio Oncotech
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
GIM9-NEO-ADIXERN
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None